You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (41)

Journals (0)

1-10 of 41 results for dual tyrosine kinase inhibitor

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Lapatinib: A Novel Dual Tyrosine Kinase Inhibitor with Activity in Solid Tumors

Retricted access

Research article

First published 2006-2

Lapatinib: A Novel Dual Tyrosine Kinase Inhibitor with Activity in Solid Tumors

Michael H Nelson, Christian R Dolder

Annals of Pharmacotherapy

Select article: Lapatinib: An Oral Dual Tyrosine Kinase Inhibitor for HER-2-Positive Breast Cancer

Free access

Research article

First published 2015-5

Lapatinib: An Oral Dual Tyrosine Kinase Inhibitor for HER-2-Positive Breast Cancer

Sagar D Sardesai, Anna Maria Storniolo

Women's Health

Select article: Design,synthesis,and antitumor activity of novel benzoheterocycle derivatives as inhibitors of vascular endothelial growth factor receptor-2 tyrosine kinase

Free access

Research article

First published 2020-5

Design,synthesis,and antitumor activity of novel benzoheterocycle derivatives as inhibitors of vascular endothelial growth factor receptor-2 tyrosine kinase

Yangyang Ding, Kai Liu, Xinyu Zhao [...]

Journal of Chemical Research

Select article: Preclinical and phase I clinical studies of KW-2450,a dual IGF-1R/IR tyrosine kinase inhibitor,in combination with lapatinib and letrozole

Open access

Research article

First published 2018

Preclinical and phase I clinical studies of KW-2450,a dual IGF-1R/IR tyrosine kinase inhibitor,in combination with lapatinib and letrozole

Hiroshi Umehara, Yoshimi Maekawa, Fumito Koizumi [...]

Therapeutic Advances in Medical Oncology

Select article: Oncogenic mechanism-based pharmaceutical validation of therapeutics targeting MET receptor tyrosine kinase

Open access

Review article

First published 2021

Oncogenic mechanism-based pharmaceutical validation of therapeutics targeting MET receptor tyrosine kinase

Hang-Ping Yao, Xiang-Min Tong, Ming-Hai Wang

Therapeutic Advances in Medical Oncology

Select article: A Review of the Management of Chronic Myeloid Leukemia with Dasatinib

Open access

Review article

First published 2009

A Review of the Management of Chronic Myeloid Leukemia with Dasatinib

Joanna Gora-Tybor, Tadeusz Robak

Clinical Medicine Insights: Therapeutics

Select article: A rare epidermal growth factor receptor T790M/cis-C797S/L718Q compound mutation in a lung adenocarcinoma patient who did not derive any benefit from combination therapy with afatinib and bevacizumab

Open access

Case report

First published 2025

A rare epidermal growth factor receptor T790M/cis-C797S/L718Q compound mutation in a lung adenocarcinoma patient who did not derive any benefit from combination therapy with afatinib and bevacizumab

Xiaopeng Meng, Jingyi Liu, Xiaohui Wu [...]

Sage Open Medical Case Reports

Select article: A Phosphotyrosine Proteomic Screen Identifies Multiple Tyrosine Kinase Signaling Pathways Aberrantly Activated in Malignant Mesothelioma

Free access

Research article

First published 2010-5

A Phosphotyrosine Proteomic Screen Identifies Multiple Tyrosine Kinase Signaling Pathways Aberrantly Activated in Malignant Mesothelioma

Craig W. Menges, Yibai Chen, Brooke T. Mossman [...]

Genes & Cancer

Select article: Lapatinib in Second-Line Treatment for Metastatic Breast Cancer: Rapid Clinical Benefit and Long-Term Response

Retricted access

Research article

First published 2013-11

Lapatinib in Second-Line Treatment for Metastatic Breast Cancer: Rapid Clinical Benefit and Long-Term Response

Michele De Tursi, Consiglia Carella

Tumori Journal

Select article: Sunitinib (Sutent®): A novel agent for the treatment of metastatic renal cell carcinoma

Retricted access

Research article

First published 2007-03

Sunitinib (Sutent®): A novel agent for the treatment of metastatic renal cell carcinoma

Jyoti D Chouhan, Daniel E Zamarripa, Phillip H Lai [...]

Journal of Oncology Pharmacy Practice

1
2
3
4
5
10 / page

Article type

Publication date

Subjects

Access